Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contraceptive Efficacy and Safety of Norelgestromine/Ethinyl Estradiol Transdermal System
NCT00307632Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2003
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of norelgestromin, ethinyl estradiol in contraception, sponsored by Janssen Pharmaceutical. Started Feb 2003; status: completed.
02
Drugs
norelgestrominethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00307632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307632.